Skip to content
中文产业新闻精选评分78Chinese source

FDA 批准 RAS(ON) 抑制剂 daraxonrasib 用于转移性胰腺癌二线及以上治疗

FDA 批准首个用于治疗转移性胰腺癌的RAS靶向疗法 daraxonrasib

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.